Applications and insights from continuous dengue virus infection in a stable cell line
Dengue is caused by the four serotypes of dengue virus (DENV-1-4) and poses a significant global public health challenge, with an estimated 100–400 million infections annually. Severe dengue manifestations, such as Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS), are influenced by imm...
Saved in:
| Main Authors: | M. Jane Morwitzer, Ying Yi Zheng, Heather Friberg, Jeffrey R. Currier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1618650/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genomic Characterization of Circulating Dengue Virus, Ethiopia, 2022–2023
by: Adugna Abera, et al.
Published: (2025-03-01) -
Emergence of Dengue Virus Serotypes 1 and 3 in Mahottari and Adjacent Areas of Southern Nepal
by: Sabin Shrestha, et al.
Published: (2025-06-01) -
Lineage B Genotype III of Dengue Virus Serotype 3 (DENV-3III_B) Is Responsible for Dengue Outbreak in Dire Dawa City, Ethiopia, 2023
by: Abebe Aseffa Negeri, et al.
Published: (2025-02-01) -
Anti-DENV-ED3 antibody cross-talks generate immune interference among the four DENVs
by: Md. Din Islam, et al.
Published: (2024-12-01) -
Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study
by: Pranjal Vats, et al.
Published: (2025-07-01)